Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
The American Journal of Cardiology|February 15, 1990
Changes in cardiac output determined by continuous-wave Doppler echocardiography during propafenone or mexiletine drug testingH Lange, S Lampert, M S Sutton, et al.The American Journal of Cardiology|August 29, 1986
Safety and efficacy of encainide for malignant ventricular arrhythmiasT Tordjman, P J Podrid, E Raeder, et al.Circulation|February 1, 1980
Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexesP J Podrid, A Lyakishev, B Lown, et al.Journal of the American College of Cardiology|November 1, 1989
Congestive heart failure induced by six of the newer antiarrhythmic drugsS Ravid, P J Podrid, S Lampert, et al.The American Journal of Cardiology|February 1, 1988
Clinical predictors of arrhythmia worsening by antiarrhythmic drugsW Slater, S Lampert, P J Podrid, et al.JAMA|July 17, 1981
Acute psychological disturbances preceding life-threatening ventricular arrhythmiasP Reich, R A DeSilva, B Lown, et al.Lancet (London, England)|October 17, 1981
Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trialsR A DeSilva, C H Hennekens, B Lown, et al.The American Journal of Cardiology|September 1, 1982
Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsT B Graboys, B Lown, P J Podrid, et al.The American Journal of Cardiology|October 16, 1987
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmiasM J Hession, S Lampert, P J Podrid, et al.Circulation|August 1, 1984
Safety of maximal exercise testing in patients at high risk for ventricular arrhythmiaD Z Young, S Lampert, T B Graboys, et al.Pageof 15